{"symbol": "RVNC", "companyName": "Revance Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.revance.com", "description": "Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.", "CEO": "L. Daniel Browne", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}